Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ · Healthcare
Orchestra BioMed Holdings, Inc. Cash Flow 2022–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Operating Cash Flow | -49.0M | -50.6M | -46.1M | -29.3M | -272,362 |
| Depreciation & Amort. | 327,000 | 308,000 | 287,000 | 222,000 | — |
| Investing Activities | |||||
| Capital Expenditure | 489,000 | 289,000 | 78,000 | 591,000 | — |
| Free Cash Flow | -49.5M | -50.8M | -46.2M | -29.9M | — |
| Financing Activities | |||||
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — |
Orchestra BioMed Holdings, Inc. Cash Flow — FAQ
Orchestra BioMed Holdings, Inc. (OBIO) cash flow over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see OBIO's cash flow history?
The chart and table above show Orchestra BioMed Holdings, Inc.'s cash flow by year and by quarter, including the growth rate.